For targeted NGS, the Accel-AmpliconTM 56G Oncology Panel covers hotspots of 56 cancer-related genes using 263 amplicons and the Accel-AmpliconTM EGFR Pathway Panel covers hotspots of EGFR, NRAS, KRAS and BRAF genes using 17 amplicons. Here, EGFR is linked to cancer.